Literature DB >> 2473749

C-terminal angiogenin peptides inhibit the biological and enzymatic activities of angiogenin.

S M Rybak1, D S Auld, D K St Clair, Q Z Yao, J W Fett.   

Abstract

Synthetic peptides corresponding to the C-terminal region of angiogenin (Ang) inhibit the enzymatic and biological activities of the molecule while peptides from the N-terminal region do not affect either activity. The peptide Ang(108-121) transiently abolishes the inhibition of cell-free protein synthesis caused by angiogenin coincidentally with its cleavage of reticulocyte RNA. Several C-terminal peptides also inhibit nuclease activity of angiogenin when tRNA is the substrate. Furthermore, peptide Ang(108-123) significantly decreases neovascularization elicited by angiogenin in the chick chorioallantoic membrane assay.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2473749     DOI: 10.1016/0006-291x(89)92030-5

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  2 in total

1.  Angiogenin antagonists prevent tumor growth in vivo.

Authors:  K A Olson; J W Fett; T C French; M E Key; B L Vallee
Journal:  Proc Natl Acad Sci U S A       Date:  1995-01-17       Impact factor: 11.205

2.  Genetic selection for peptide inhibitors of angiogenin.

Authors:  Bryan D Smith; Ronald T Raines
Journal:  Protein Eng Des Sel       Date:  2008-02-28       Impact factor: 1.650

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.